List of Figures

FIGURE 1 RESEARCH DESIGN 22
FIGURE 2 BREAKDOWN OF PRIMARIES: GLOBAL SEPSIS DIAGNOSTICS MARKET 25
FIGURE 3 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 26
FIGURE 4 MARKET SIZE ESTIMATION: SEPSIS DIAGNOSTICS MARKET 28
FIGURE 5 DATA TRIANGULATION METHODOLOGY 29
FIGURE 6 SEPSIS DIAGNOSTICS MARKET, BY PRODUCT, 2019 VS 2025 31
FIGURE 7 SEPSIS DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019 VS 2025 32
FIGURE 8 SEPSIS DIAGNOSTICS MARKET, BY METHOD, 2019 VS 2025 32
FIGURE 9 SEPSIS DIAGNOSTICS MARKET, BY TEST TYPE, 2019 VS 2025 33
FIGURE 10 SEPSIS DIAGNOSTICS MARKET, BY PATHOGEN, 2019 VS 2025 34
FIGURE 11 SEPSIS DIAGNOSTICS MARKET, BY END USER, 2018 34
FIGURE 12 GLOBAL SEPSIS DIAGNOSTICS MARKET, BY REGION, 2019 (USD MILLION) 35
FIGURE 13 RISING PREVALENCE OF SEPSIS IS DRIVING DEMAND FOR DIAGNOSTICS 36
FIGURE 14 BLOOD CULTURE SEGMENT WILL DOMINATE THE MARKET DURING 2019–2025 37
FIGURE 15 BLOOD CULTURE MEDIA SEGMENT TO DOMINATE THE GLOBAL SEPSIS DIAGNOSTICS PRODUCTS MARKET IN 2019 38
FIGURE 16 HOSPITALS SEGMENT TO DOMINATE THE ASIA PACIFIC MARKET DURING THE FORECAST PERIOD 38
FIGURE 17 GRAM-NEGATIVE BACTERIAL SEPSIS HOLDS LARGEST SHARE OF THE GLOBAL MARKET, BY PATHOGEN 39
FIGURE 18 ASIA PACIFIC TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD 39
FIGURE 19 SEPSIS DIAGNOSTICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 40
FIGURE 20 NORTH AMERICA: SEPSIS DIAGNOSTICS MARKET SNAPSHOT 96
FIGURE 21 APAC: SEPSIS DIAGNOSTICS MARKET SNAPSHOT 114
FIGURE 22 KEY DEVELOPMENTS BY LEADING MARKET PLAYERS IN THE SEPSIS DIAGNOSTICS MARKET, 2016–2019 135
FIGURE 23 SEPSIS DIAGNOSTICS MARKET SHARE, BY KEY PLAYERS, 2018 136
FIGURE 24 SEPSIS DIAGNOSTICS MARKET (GLOBAL) COMPETITIVE LEADERSHIP
MAPPING, 2019 140
FIGURE 25 BIOM?RIEUX: COMPANY SNAPSHOT 141
FIGURE 26 BD: COMPANY SNAPSHOT 144
FIGURE 27 DANAHER: COMPANY SNAPSHOT 146
FIGURE 28 T2 BIOSYSTEMS: COMPANY SNAPSHOT (2019) 150
FIGURE 29 LUMINEX: COMPANY SNAPSHOT 152
FIGURE 30 ROCHE DIAGNOSTICS: COMPANY SNAPSHOT 154
FIGURE 31 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT 157
FIGURE 32 BRUKER: COMPANY SNAPSHOT 160
FIGURE 33 ABBOTT: COMPANY SNAPSHOT 163
FIGURE 34 CYTOSORBENTS: COMPANY SNAPSHOT 168
FIGURE 35 MITSUBISHI CHEMICAL EUROPE: COMPANY SNAPSHOT 171
FIGURE 36 EKF DIAGNOSTICS: COMPANY SNAPSHOT 172

 

List of Tables

TABLE 1 SEPSIS DIAGNOSTICS MARKET, BY TECHNOLOGY, 2017–2025 (USD MILLION) 47
TABLE 2 BLOOD CULTURE MARKET FOR SEPSIS DIAGNOSTICS, BY REGION 2017–2025 (USD MILLION) 48
TABLE 3 BLOOD CULTURE MARKET FOR SEPSIS DIAGNOSTICS, BY PRODUCT 2017–2025 (USD MILLION) 48
TABLE 4 BLOOD CULTURE MARKET FOR SEPSIS DIAGNOSTICS, BY METHOD 2017–2025 (USD MILLION) 48
TABLE 5 BLOOD CULTURE MARKET FOR SEPSIS DIAGNOSTICS, BY PATHOGEN 2017–2025 (USD MILLION) 49
TABLE 6 BLOOD CULTURE MARKET FOR SEPSIS DIAGNOSTICS, BY TEST TYPE 2017–2025 (USD MILLION) 49
TABLE 7 BLOOD CULTURE MARKET FOR SEPSIS DIAGNOSTICS, BY END USER 2017–2025 (USD MILLION) 49
TABLE 8 IMMUNOASSAYS MARKET FOR SEPSIS DIAGNOSTICS, BY REGION 2017–2025 (USD MILLION) 51
TABLE 9 IMMUNOASSAYS MARKET FOR SEPSIS DIAGNOSTICS, BY PRODUCT 2017–2025 (USD MILLION) 51
TABLE 10 IMMUNOASSAYS MARKET FOR SEPSIS DIAGNOSTICS, BY METHOD 2017–2025 (USD MILLION) 51
TABLE 11 IMMUNOASSAYS MARKET FOR SEPSIS DIAGNOSTICS, BY PATHOGEN 2017–2025 (USD MILLION) 52
TABLE 12 IMMUNOASSAYS MARKET FOR SEPSIS DIAGNOSTICS, BY TEST TYPE 2017–2025 (USD MILLION) 52
TABLE 13 IMMUNOASSAYS MARKET FOR SEPSIS DIAGNOSTICS, BY END USER 2017–2025 (USD MILLION) 52
TABLE 14 MOLECULAR DIAGNOSTICS MARKET FOR SEPSIS DIAGNOSTICS, BY TECHNIQUE, 2017–2025 (USD MILLION) 53
TABLE 15 MOLECULAR DIAGNOSTICS MARKET FOR SEPSIS DIAGNOSTICS, BY REGION, 2017–2025 (USD MILLION) 53
TABLE 16 MOLECULAR DIAGNOSTICS MARKET FOR SEPSIS DIAGNOSTICS, BY PRODUCT, 2017–2025 (USD MILLION) 54
TABLE 17 MOLECULAR DIAGNOSTICS MARKET FOR SEPSIS DIAGNOSTICS, BY METHOD, 2017–2025 (USD MILLION) 54
TABLE 18 MOLECULAR DIAGNOSTICS MARKET FOR SEPSIS DIAGNOSTICS, BY PATHOGEN, 2017–2025 (USD MILLION) 54
TABLE 19 MOLECULAR DIAGNOSTICS MARKET FOR SEPSIS DIAGNOSTICS, BY TEST TYPE, 2017–2025 (USD MILLION) 55
TABLE 20 MOLECULAR DIAGNOSTICS MARKET FOR SEPSIS DIAGNOSTICS, BY END USER, 2017–2025 (USD MILLION) 55
TABLE 21 PCR MARKET FOR SEPSIS DIAGNOSTICS, BY REGION, 2017–2025 (USD MILLION) 56
TABLE 22 PCR MARKET FOR SEPSIS DIAGNOSTICS, BY PRODUCT 2017–2025 (USD MILLION) 56
TABLE 23 PCR MARKET FOR SEPSIS DIAGNOSTICS, BY METHOD, 2017–2025 (USD MILLION) 56
TABLE 24 PCR MARKET FOR SEPSIS DIAGNOSTICS, BY PATHOGEN 2017–2025 (USD MILLION) 56
TABLE 25 PCR MARKET FOR SEPSIS DIAGNOSTICS, BY TEST TYPE 2017–2025 (USD MILLION) 57
TABLE 26 PCR MARKET FOR SEPSIS DIAGNOSTICS, BY END USER 2017–2025 (USD MILLION) 57
TABLE 27 MICROARRAYS MARKET FOR SEPSIS DIAGNOSTICS, BY REGION 2017–2025 (USD MILLION) 58
TABLE 28 MICROARRAYS MARKET FOR SEPSIS DIAGNOSTICS, BY PRODUCT 2017–2025 (USD MILLION) 58
TABLE 29 MICROARRAYS MARKET FOR SEPSIS DIAGNOSTICS, BY METHOD 2017–2025 (USD MILLION) 58
TABLE 30 MICROARRAYS MARKET FOR SEPSIS DIAGNOSTICS, BY PATHOGEN 2017–2025 (USD MILLION) 59
TABLE 31 MICROARRAYS MARKET FOR SEPSIS DIAGNOSTICS, BY TEST TYPE 2017–2025 (USD MILLION) 59
TABLE 32 MICROARRAYS MARKET FOR SEPSIS DIAGNOSTICS, BY END USER 2017–2025 (USD MILLION) 59
TABLE 33 PNA-FISH MARKET FOR SEPSIS DIAGNOSTICS, BY REGION 2017–2025 (USD MILLION) 60
TABLE 34 PNA-FISH MARKET FOR SEPSIS DIAGNOSTICS, BY PRODUCT 2017–2025 (USD MILLION) 60
TABLE 35 PNA-FISH MARKET FOR SEPSIS DIAGNOSTICS, BY METHOD 2017–2025 (USD MILLION) 60
TABLE 36 PNA-FISH MARKET FOR SEPSIS DIAGNOSTICS, BY PATHOGEN 2017–2025 (USD MILLION) 61
TABLE 37 PNA-FISH MARKET FOR SEPSIS DIAGNOSTICS, BY TEST TYPE 2017–2025 (USD MILLION) 61
TABLE 38 PNA-FISH MARKET FOR SEPSIS DIAGNOSTICS, BY END USER 2017–2025 (USD MILLION) 61
TABLE 39 SYNDROMIC PANEL-BASED TESTING MARKET FOR SEPSIS DIAGNOSTICS BY REGION, 2017–2025 (USD MILLION) 62
TABLE 40 SYNDROMIC PANEL-BASED TESTING MARKET FOR SEPSIS DIAGNOSTICS BY PRODUCT, 2017–2025 (USD MILLION) 62
TABLE 41 SYNDROMIC PANEL-BASED TESTING MARKET FOR SEPSIS DIAGNOSTICS BY METHOD, 2017–2025 (USD MILLION) 62
TABLE 42 SYNDROMIC PANEL-BASED TESTING MARKET FOR SEPSIS DIAGNOSTICS BY PATHOGEN, 2017–2025 (USD MILLION) 63
TABLE 43 SYNDROMIC PANEL-BASED TESTING MARKET FOR SEPSIS DIAGNOSTICS, BY TEST TYPE, 2017–2025 (USD MILLION) 63
TABLE 44 SYNDROMIC PANEL-BASED TESTING MARKET FOR SEPSIS DIAGNOSTICS BY END USER, 2017–2025 (USD MILLION) 63
TABLE 45 FLOW CYTOMETRY MARKET FOR SEPSIS DIAGNOSTICS, BY REGION 2017–2025 (USD MILLION) 64
TABLE 46 FLOW CYTOMETRY MARKET FOR SEPSIS DIAGNOSTICS, BY PRODUCT 2017–2025 (USD MILLION) 64
TABLE 47 FLOW CYTOMETRY MARKET FOR SEPSIS DIAGNOSTICS, BY METHOD 2017–2025 (USD MILLION) 65
TABLE 48 FLOW CYTOMETRY MARKET FOR SEPSIS DIAGNOSTICS, BY PATHOGEN 2017–2025 (USD MILLION) 65
TABLE 49 FLOW CYTOMETRY MARKET FOR SEPSIS DIAGNOSTICS, BY TEST TYPE 2017–2025 (USD MILLION) 65
TABLE 50 FLOW CYTOMETRY MARKET FOR SEPSIS DIAGNOSTICS, BY END USER 2017–2025 (USD MILLION) 65
TABLE 51 MICROFLUIDICS MARKET FOR SEPSIS DIAGNOSTICS, BY REGION 2017–2025 (USD MILLION) 66
TABLE 52 MICROFLUIDICS MARKET FOR SEPSIS DIAGNOSTICS, BY PRODUCT 2017–2025 (USD MILLION) 67
TABLE 53 MICROFLUIDICS MARKET FOR SEPSIS DIAGNOSTICS, BY METHOD 2017–2025 (USD MILLION) 67
TABLE 54 MICROFLUIDICS MARKET FOR SEPSIS DIAGNOSTICS, BY PATHOGEN 2017–2025 (USD MILLION) 67
TABLE 55 MICROFLUIDICS MARKET FOR SEPSIS DIAGNOSTICS, BY TEST TYPE 2017–2025 (USD MILLION) 68
TABLE 56 MICROFLUIDICS MARKET FOR SEPSIS DIAGNOSIS, BY END USER 2017 – 2025 (USD MILLION) 68
TABLE 57 BIOMARKERS MARKET FOR SEPSIS DIAGNOSTICS, BY REGION 2017–2025 (USD MILLION) 69
TABLE 58 BIOMARKERS MARKET FOR SEPSIS DIAGNOSTICS, BY PRODUCT 2017–2025 (USD MILLION) 69
TABLE 59 BIOMARKERS MARKET FOR SEPSIS DIAGNOSTICS, BY METHOD 2017–2025 (USD MILLION) 69
TABLE 60 BIOMARKERS MARKET FOR SEPSIS DIAGNOSTICS, BY PATHOGEN 2017–2025 (USD MILLION) 70
TABLE 61 BIOMARKERS MARKET FOR SEPSIS DIAGNOSTICS, BY TEST TYPE 2017–2025 (USD MILLION) 70
TABLE 62 BIOMARKERS MARKET FOR SEPSIS DIAGNOSTICS, BY END USER 2017–2025 (USD MILLION) 70
TABLE 63 SEPSIS DIAGNOSTICS MARKET, BY PRODUCT, 2017–2025 (USD MILLION) 72
TABLE 64 SEPSIS DIAGNOSTIC BLOOD CULTURE MEDIA MARKET, BY REGION 2017–2025 (USD MILLION) 72
TABLE 65 SEPSIS DIAGNOSTIC ASSAYS & REAGENTS MARKET, BY REGION 2017–2025 (USD MILLION) 73
TABLE 66 SEPSIS DIAGNOSTIC INSTRUMENTS MARKET, BY REGION 2017–2025 (USD MILLION) 74
TABLE 67 SEPSIS DIAGNOSTIC SOFTWARE MARKET, BY REGION, 2017–2025 (USD MILLION) 75
TABLE 68 SEPSIS DIAGNOSTICS MARKET, BY METHOD, 2017–2025 (USD MILLION) 77
TABLE 69 CONVENTIONAL DIAGNOSTICS MARKET, BY REGION, 2017–2025 (USD MILLION) 78
TABLE 70 AUTOMATED DIAGNOSTICS MARKET, BY REGION, 2017–2025 (USD MILLION) 79
TABLE 71 SEPSIS DIAGNOSTICS MARKET, BY PATHOGEN, 2017–2025 (USD MILLION) 81
TABLE 72 BACTERIAL SEPSIS MARKET, BY TYPE, 2017–2025 (USD MILLION) 81
TABLE 73 BACTERIAL SEPSIS MARKET, BY REGION, 2019–2025 (USD MILLION) 82
TABLE 74 CAUSES OF ADULT SEPSIS: GRAM-NEGATIVE BACTERIA 82
TABLE 75 GRAM-NEGATIVE BACTERIAL SEPSIS MARKET, BY REGION 2019–2025 (USD MILLION) 83
TABLE 76 CAUSES OF ADULT SEPSIS: GRAM-POSITIVE BACTERIA 83
TABLE 77 GRAM-POSITIVE BACTERIAL SEPSIS MARKET, BY REGION 2019–2025 (USD MILLION) 84
TABLE 78 FUNGAL SEPSIS MARKET, BY REGION, 2019–2025 (USD MILLION) 84
TABLE 79 OTHER PATHOGENS MARKET, BY REGION, 2017–2025 (USD MILLION) 85
TABLE 80 SEPSIS DIAGNOSTICS MARKET, BY TEST TYPE, 2017–2025 (USD MILLION) 87
TABLE 81 LABORATORY SEPSIS DIAGNOSTIC TESTS MARKET, BY REGION 2017–2025 (USD MILLION) 88
TABLE 82 POINT-OF-CARE SEPSIS DIAGNOSTIC TESTS MARKET, BY REGION 2017–2025 (USD MILLION) 89
TABLE 83 SEPSIS DIAGNOSTICS MARKET, BY END USER, 2017–2025 (USD MILLION) 91
TABLE 84 SEPSIS DIAGNOSTICS MARKET FOR HOSPITALS, BY REGION 2017–2025 (USD MILLION) 92
TABLE 85 SEPSIS DIAGNOSTICS MARKET FOR PATHOLOGY & REFERENCE LABORATORIES, BY REGION, 2017–2025 (USD MILLION) 92
TABLE 86 SEPSIS DIAGNOSTICS MARKET FOR RESEARCH LABORATORIES & ACADEMIC INSTITUTES, BY REGION, 2017–2025 (USD MILLION) 93
TABLE 87 SEPSIS DIAGNOSTICS MARKET, BY REGION, 2017–2025 (USD MILLION) 95
TABLE 88 NORTH AMERICA: SEPSIS DIAGNOSTICS MARKET, BY COUNTRY 2017–2025 (USD MILLION) 96
TABLE 89 NORTH AMERICA: SEPSIS DIAGNOSTICS MARKET, BY TECHNOLOGY 2017–2025 (USD MILLION) 97
TABLE 90 NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET FOR SEPSIS DIAGNOSTICS, BY TECHNIQUE, 2017–2025 (USD MILLION) 97
TABLE 91 NORTH AMERICA: SEPSIS DIAGNOSTICS MARKET, BY PRODUCT 2017–2025 (USD MILLION) 97
TABLE 92 NORTH AMERICA: SEPSIS DIAGNOSTICS MARKET, BY PATHOGEN 2017–2025 (USD MILLION) 98
TABLE 93 NORTH AMERICA: SEPSIS DIAGNOSTICS MARKET, BY METHOD 2017–2025 (USD MILLION) 98
TABLE 94 NORTH AMERICA: SEPSIS DIAGNOSTICS MARKET, BY TEST TYPE 2017–2025 (USD MILLION) 98
TABLE 95 NORTH AMERICA: SEPSIS DIAGNOSTICS MARKET, BY END USER 2017–2025 (USD MILLION) 98
TABLE 96 US: SEPSIS DIAGNOSTICS MARKET, BY TECHNOLOGY, 2017–2025 (USD MILLION) 100
TABLE 97 US: MOLECULAR DIAGNOSTICS MARKET FOR SEPSIS DIAGNOSTICS BY TECHNIQUE, 2017–2025 (USD MILLION) 101
TABLE 98 CANADA: SEPSIS DIAGNOSTICS MARKET, BY TECHNOLOGY 2017–2025 (USD MILLION) 102
TABLE 99 CANADA: MOLECULAR DIAGNOSTICS MARKET FOR SEPSIS DIAGNOSTICS BY TECHNIQUE, 2017–2025 (USD MILLION) 102
TABLE 100 EUROPE: SEPSIS DIAGNOSTICS MARKET, BY COUNTRY 2017–2025 (USD MILLION) 103
TABLE 101 EUROPE: SEPSIS DIAGNOSTICS MARKET, BY TECHNOLOGY 2017–2025 (USD MILLION) 103
TABLE 102 EUROPE: MOLECULAR DIAGNOSTICS MARKET FOR SEPSIS DIAGNOSTICS BY TECHNIQUE, 2017–2025 (USD MILLION) 104
TABLE 103 EUROPE: SEPSIS DIAGNOSTICS MARKET, BY PRODUCT 2017–2025 (USD MILLION) 104
TABLE 104 EUROPE: SEPSIS DIAGNOSTICS MARKET, BY PATHOGEN 2017–2025 (USD MILLION) 104
TABLE 105 EUROPE: SEPSIS DIAGNOSTICS MARKET, BY METHOD, 2017–2025 (USD MILLION) 105
TABLE 106 EUROPE: SEPSIS DIAGNOSTICS MARKET, BY TEST TYPE 2017–2025 (USD MILLION) 105
TABLE 107 EUROPE: SEPSIS DIAGNOSTICS MARKET, BY END USER 2017–2025 (USD MILLION) 105
TABLE 108 GERMANY: SEPSIS DIAGNOSTICS MARKET, BY TECHNOLOGY 2017–2025 (USD MILLION) 107
TABLE 109 GERMANY: MOLECULAR DIAGNOSTICS MARKET FOR SEPSIS DIAGNOSTICS BY TECHNIQUE, 2017–2025 (USD MILLION) 107
TABLE 110 FRANCE: SEPSIS DIAGNOSTICS MARKET, BY TECHNOLOGY 2017–2025 (USD MILLION) 108
TABLE 111 FRANCE: MOLECULAR DIAGNOSTICS MARKET FOR SEPSIS DIAGNOSTICS BY TECHNIQUE, 2017–2025 (USD MILLION) 108
TABLE 112 UK: SEPSIS DIAGNOSTICS MARKET, BY TECHNOLOGY, 2017–2025 (USD MILLION) 110
TABLE 113 UK: MOLECULAR DIAGNOSTICS MARKET FOR SEPSIS DIAGNOSTICS BY TECHNIQUE, 2017–2025 (USD MILLION) 110
TABLE 114 ITALY: SEPSIS DIAGNOSTICS MARKET, BY TECHNOLOGY 2017–2025 (USD MILLION) 111
TABLE 115 ITALY: MOLECULAR DIAGNOSTICS MARKET FOR SEPSIS DIAGNOSTICS BY TECHNIQUE, 2017–2025 (USD MILLION) 111
TABLE 116 SPAIN: SEPSIS DIAGNOSTICS MARKET, BY TECHNOLOGY 2017–2025 (USD MILLION) 112
TABLE 117 SPAIN: MOLECULAR DIAGNOSTICS MARKET FOR SEPSIS DIAGNOSTICS BY TECHNIQUE, 2017–2025 (USD MILLION) 112
TABLE 118 REST OF EUROPE: SEPSIS DIAGNOSTICS MARKET, BY TECHNOLOGY 2017–2025 (USD MILLION) 113
TABLE 119 REST OF EUROPE: MOLECULAR DIAGNOSTICS MARKET FOR SEPSIS DIAGNOSTICS, BY TECHNIQUE, 2017–2025 (USD MILLION) 113
TABLE 120 ASIA PACIFIC: SEPSIS DIAGNOSTICS MARKET, BY COUNTRY 2017–2025 (USD MILLION) 115
TABLE 121 ASIA PACIFIC: SEPSIS DIAGNOSTICS MARKET, BY TECHNOLOGY 2017–2025 (USD MILLION) 115
TABLE 122 ASIA PACIFIC: MOLECULAR DIAGNOSTICS MARKET FOR SEPSIS DIAGNOSTICS BY TECHNIQUE, 2017–2025 (USD MILLION) 115
TABLE 123 ASIA PACIFIC: SEPSIS DIAGNOSTICS MARKET, BY PRODUCT 2017–2025 (USD MILLION) 116
TABLE 124 ASIA PACIFIC: SEPSIS DIAGNOSTICS MARKET, BY PATHOGEN 2017–2025 (USD MILLION) 116
TABLE 125 ASIA PACIFIC: SEPSIS DIAGNOSTICS MARKET, BY METHOD 2017–2025 (USD MILLION) 116
TABLE 126 ASIA PACIFIC: SEPSIS DIAGNOSTICS MARKET, BY TEST TYPE 2017–2025 (USD MILLION) 117
TABLE 127 ASIA PACIFIC: SEPSIS DIAGNOSTICS MARKET, BY END USER 2017–2025 (USD MILLION) 117
TABLE 128 JAPAN: SEPSIS DIAGNOSTICS MARKET, BY TECHNOLOGY 2017–2025 (USD MILLION) 118
TABLE 129 JAPAN: MOLECULAR DIAGNOSTICS MARKET FOR SEPSIS DIAGNOSTICS BY TECHNIQUE, 2017–2025 (USD MILLION) 118
TABLE 130 CHINA: SEPSIS DIAGNOSTICS MARKET, BY TECHNOLOGY 2017–2025 (USD MILLION) 119
TABLE 131 CHINA: MOLECULAR DIAGNOSTICS MARKET FOR SEPSIS DIAGNOSTICS BY TECHNIQUE, 2017–2025 (USD MILLION) 120
TABLE 132 INDIA: SEPSIS DIAGNOSTICS MARKET, BY TECHNOLOGY 2017–2025 (USD MILLION) 121
TABLE 133 INDIA: MOLECULAR DIAGNOSTICS MARKET FOR SEPSIS DIAGNOSTICS BY TECHNIQUE, 2017–2025 (USD MILLION) 121
TABLE 134 AUSTRALIA: SEPSIS DIAGNOSTICS MARKET, BY TECHNOLOGY 2017–2025 (USD MILLION) 122
TABLE 135 AUSTRALIA: MOLECULAR DIAGNOSTICS MARKET FOR SEPSIS DIAGNOSTICS BY TECHNIQUE, 2017–2025 (USD MILLION) 123
TABLE 136 SOUTH KOREA: SEPSIS DIAGNOSTICS MARKET, BY TECHNOLOGY 2017–2025 (USD MILLION) 123
TABLE 137 SOUTH KOREA: MOLECULAR DIAGNOSTICS MARKET FOR SEPSIS DIAGNOSTICS BY TECHNIQUE, 2017–2025 (USD MILLION) 124
TABLE 138 REST OF ASIA PACIFIC: SEPSIS DIAGNOSTICS MARKET, BY TECHNOLOGY 2017–2025 (USD MILLION) 125
TABLE 139 REST OF ASIA PACIFIC: MOLECULAR DIAGNOSTICS MARKET FOR SEPSIS DIAGNOSTICS, BY TECHNIQUE, 2017–2025 (USD MILLION) 125
TABLE 140 LATIN AMERICA: SEPSIS DIAGNOSTICS MARKET, BY COUNTRY 2017–2025 (USD MILLION) 126
TABLE 141 LATIN AMERICA: SEPSIS DIAGNOSTICS MARKET, BY TECHNOLOGY 2017–2025 (USD MILLION) 126
TABLE 142 LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET FOR SEPSIS DIAGNOSTICS, BY TECHNIQUE, 2017–2025 (USD MILLION) 127
TABLE 143 LATIN AMERICA: SEPSIS DIAGNOSTICS MARKET, BY PRODUCT 2017–2025 (USD MILLION) 127
TABLE 144 LATIN AMERICA: SEPSIS DIAGNOSTICS MARKET, BY PATHOGEN 2017–2025 (USD MILLION) 127
TABLE 145 LATIN AMERICA: SEPSIS DIAGNOSTICS MARKET, BY METHOD 2017–2025 (USD MILLION) 128
TABLE 146 LATIN AMERICA: SEPSIS DIAGNOSTICS MARKET, BY TEST TYPE 2017–2025 (USD MILLION) 128
TABLE 147 LATIN AMERICA: SEPSIS DIAGNOSTICS MARKET, BY END USER 2017–2025 (USD MILLION) 128
TABLE 148 BRAZIL: SEPSIS DIAGNOSTICS MARKET, BY TECHNOLOGY 2017–2025 (USD MILLION) 129
TABLE 149 BRAZIL: MOLECULAR DIAGNOSTICS MARKET FOR SEPSIS DIAGNOSTICS BY TECHNIQUE, 2017–2025 (USD MILLION) 129
TABLE 150 MEXICO: SEPSIS DIAGNOSTICS MARKET, BY TECHNOLOGY 2017–2025 (USD MILLION) 130
TABLE 151 MEXICO: MOLECULAR DIAGNOSTICS MARKET FOR SEPSIS DIAGNOSTICS BY TECHNIQUE, 2017–2025 (USD MILLION) 130
TABLE 152 REST OF LATIN AMERICA: SEPSIS DIAGNOSTICS MARKET, BY TECHNOLOGY 2017–2025 (USD MILLION) 131
TABLE 153 REST OF LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET FOR SEPSIS DIAGNOSTICS, BY TECHNIQUE, 2017–2025 (USD MILLION) 131
TABLE 154 MIDDLE EAST AND AFRICA: SEPSIS DIAGNOSTICS MARKET, BY TECHNOLOGY, 2017–2025 (USD MILLION) 132
TABLE 155 MIDDLE EAST AND AFRICA: MOLECULAR DIAGNOSTICS MARKET FOR SEPSIS DIAGNOSTICS, BY TECHNIQUE, 2017–2025 (USD MILLION) 133
TABLE 156 MIDDLE EAST AND AFRICA: SEPSIS DIAGNOSTICS MARKET, BY PRODUCT 2017–2025 (USD MILLION) 133
TABLE 157 MIDDLE EAST AND AFRICA: SEPSIS DIAGNOSTICS MARKET, BY PATHOGEN 2017–2025 (USD MILLION) 133
TABLE 158 MIDDLE EAST AND AFRICA: SEPSIS DIAGNOSTICS MARKET, BY METHOD 2017–2025 (USD MILLION) 134
TABLE 159 MIDDLE EAST AND AFRICA: SEPSIS DIAGNOSTICS MARKET, BY TEST TYPE 2017–2025 (USD MILLION) 134
TABLE 160 MIDDLE EAST AND AFRICA: SEPSIS DIAGNOSTICS MARKET, BY END USER 2017–2025 (USD MILLION) 134